1. Amano M, Yamada K, Matsuno K, Nabeshima T. Neuropharmacological effects of sigma ligands: Anxiolytic, antiamnesic and neuroprotective effects (abstract in English).Jpn J Psychopharmacol 16: 73–84, 1996.
2. Bem WT, Thomas GE, Mamone JY, Homan SM, Levy BK, Johnson FE, et al. Overexpression of σ receptors in nonneural human tumors.Cancer Res 51: 6558–6562, 1991.
3. Collier TL, O'Brien JC, Waterhouse RN. Synthesis of [18F]-1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a potential sigma-1 receptor radioligands for PET.J Label Compds Radiopharm 38: 786–794, 1996.
4. Dence CS, John CS, Bowen WD, Welch MJ. Synthesis and evaluation of [18F] labeled benzamides: High affinity sigma receptor ligands for PET imaging.Nucl Med Biol 24: 333–340, 1997.
5. Ding YS, Fowler JS, Dewey SL, Wolf AP, Logan J Gatley SJ, et al. Synthesis and PET studies of fluorine-18-BMY14802: A potential antipsychotic drug.J Nucl Med 34: 246–254, 1993.